total assets (36,492): $1,225.98T
real estate: $446.62T
commodities (16): $374.39T
companies (20,681): $148.67T
currencies (112): $136.54T
govt bonds (177): $117.63T
cryptos (10,287): $2.14T
Sign up

Get the App

Scan with your phone to download. 35,000+ assets in your pocket.

Google Play QR code Google Play
App Store

The global leaderboard of wealth: $1.2 Quadrillion of Assets ranked by Market Cap

Companies

Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease - Slideshow

By seekingalpha.com · · 1 min read
Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease - Slideshow

Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease - Slideshow

Read the full article on seekingalpha.com

Comments 0

No comments yet. Be the first to share your thoughts!

← All News articles
—— As Seen On ——